These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8693593)

  • 1. Role of three cancer "master genes" p53, bcl2 and c-myc on the apoptotic process.
    Chiarugi V; Ruggiero M
    Tumori; 1996; 82(3):205-9. PubMed ID: 8693593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
    Sharma K; Patel YC; Srikant CB
    Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of BCL2 family member MCL1 as an early response to DNA damage.
    Zhan Q; Bieszczad CK; Bae I; Fornace AJ; Craig RW
    Oncogene; 1997 Mar; 14(9):1031-9. PubMed ID: 9070651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle.
    Ryan JJ; Prochownik E; Gottlieb CA; Apel IJ; Merino R; Nuñez G; Clarke MF
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5878-82. PubMed ID: 8016082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant oncogenes, tumor suppressors, and radiosensitivity.
    Chiarugi V; Magnelli L; Cinelli M; Turchetti A; Ruggiero M
    Cell Mol Biol Res; 1995; 41(3):161-6. PubMed ID: 8589756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diversity of signal transduction pathways which induce apoptosis of thymocytes. Role of bcl-2, pim-1, c-myc and p53 genes in selection processes of thymocytes].
    Matuszyk J; Strzadała L
    Postepy Hig Med Dosw; 1994; 48(6):663-75. PubMed ID: 7675728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
    Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2.
    Yu K; Ravera CP; Chen YN; McMahon G
    Cell Growth Differ; 1997 Jul; 8(7):731-42. PubMed ID: 9218867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of apoptosis and cell cycle related genes in proliferating and colcemid arrested cells of divergent lineage.
    Gallaher BW; Berthold A; Klammt J; Knüpfer M; Kratzsch J; Bartsch M; Kiess W
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):79-88. PubMed ID: 10726974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular bases of the programmed cell death process: implications of tumor suppressor protein p53 and other proteins in the control of cell cycle. Mechanisms of apoptotic action. Review].
    Merino JJ; Cordero-Campaña MI
    Invest Clin; 1998 Dec; 39(4):323-58. PubMed ID: 9927805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
    Wang Y; Szekely L; Okan I; Klein G; Wiman KG
    Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
    Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
    Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of p53-induced G1 arrest by the HPV 16 E7 protein does not inhibit p53-induced apoptosis.
    Wang Y; Okan I; Pokrovskaja K; Wiman KG
    Oncogene; 1996 Jun; 12(12):2731-5. PubMed ID: 8700534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect.
    Osanai M; Ogawa K; Lee GH
    Cancer Res; 1997 Jul; 57(14):2896-903. PubMed ID: 9230198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes.
    Lotem J; Sachs L
    Leukemia; 1996 Jun; 10(6):925-31. PubMed ID: 8667646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
    Srivastava P; Russo J; Mgbonyebi OP; Russo IH
    Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.